Tenaya Therapeutics, Inc. (NASDAQ:TNYA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eli Casdin Other companies: GeneDx Holdings Corp. (Board Member · Since at least Apr 27, 2022); Standard BioTools Inc. (Director · Since at least Apr 4, 2022); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past); EQRx Inc (Director · Sep 30, 2022 – Sep 30, 2022 · Past); Century Therapeutics, Inc. (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Absci Corporation (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Director · Jun 10, 2022 – Nov 17, 2022 · Past |
| Leone Patterson Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Apr 3, 2025); Zymeworks Inc. (EVP, Chief Bus & Fin Officer · Since at least Sep 1, 2024); Nkarta, Inc. (Director · Since at least Jun 8, 2022); Climb Bio, Inc. (Director · May 19, 2022 – May 19, 2022 · Past) | Chief Fin. and Bus. Officer · Feb 15, 2023 – Feb 23, 2024 · Past |
| Catherine Stehman-Breen Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Generation Bio Co (Director · Since at least Jun 11, 2020); Sarepta Therapeutics, Inc. (SVP, Chief Medical Officer · Apr 3, 2017 – Apr 3, 2017 · Past) | Board Member · Since at least Jul 29, 2021 |
| David V Goeddel Other companies: Nurix Therapeutics, Inc. (Director · Jul 28, 2020 – Jul 28, 2020 · Past); RAPT Therapeutics Inc (Director · Oct 30, 2019 – Nov 4, 2019 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past) | Director · Since at least Jul 29, 2021 |
| R. Sanders Williams Other companies: Amgen Inc. (Director · Oct 17, 2014 – May 19, 2023 · Past); Labcorp Holdings Inc. (Director · May 16, 2007 – Feb 6, 2024 · Past); Bristol-Myers Squibb Company (Director · Sep 11, 2006 – Feb 1, 2013 · Past) | Chair of the Board · Since at least Jul 29, 2021 |
| Eric Hyllengren Other companies: Zura Bio Limited (Chief Financial Officer · Since at least Jul 1, 2025); Atara Biotherapeutics, Inc. (EVP, CFO and COO · Apr 1, 2023 – Mar 3, 2025 · Past) | Chief Financial Officer · Since at least Jun 29, 2026 |
| Karah Parschauer Other companies: Ultragenyx Pharmaceutical Inc. (EVP and Chief Legal Officer · Since at least Mar 1, 2024); Evolus, Inc. Common Stock (Director · Since at least Jan 30, 2024) | Board Member · Since at least Oct 18, 2024 |
| Amy Burroughs Other companies: Terns Pharmaceuticals, Inc. (Chief Executive Officer, Director · Since at least Feb 7, 2024) | Board Member · Since at least Oct 18, 2024 |
| Faraz Ali Other companies: Regenxbio Inc. (Chief Business Officer · Feb 29, 2016 – Jan 4, 2017 · Past) | Chief Executive Officer · Since at least Jul 29, 2021 |
| Jeffrey T. Walsh Other companies: Bluebird bio Inc (Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past) | Board Member · Since at least Jul 29, 2021 |
| Jin-Long Chen Other companies: NGM Biopharmaceuticals Inc (Chief Scientific Officer, Director · Apr 3, 2019 – Mar 2, 2023 · Past) | Director · Jul 29, 2021 – Jun 9, 2023 · Past |
| June Lee Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Jan 10, 2025) | Board Member · Since at least Oct 18, 2024 |
| Chihiro Saito | SVP, Accounting and Fin. Ops. · Aug 14, 2024 – Nov 18, 2024 · Past |
| Deepak Srivastava | Board Member · Since at least Jul 29, 2021 |
| Hiro Higa | Senior Vice President · Until Jun 29, 2026 · Past |
| Jay Vora | Senior Vice President, Portfolio and Program Management · Since at least Nov 4, 2026 |
| Jennifer Drimmer | General Counsel · Since at least Nov 4, 2026 |
| Joanna Auch | Senior Vice President, People and Culture · Since at least Nov 4, 2026 |
| Kathy Ivey | Senior Vice President, Research · Since at least Mar 9, 2026 |
| Kee-Hong Kim | Chief Technology Officer · Since at least Nov 4, 2026 |
| Timothy Hoey | Chief Scientific Officer · Apr 26, 2022 – Mar 5, 2024 · Past |
| Tomohiro Higa | SVP, Finance · Since at least Feb 6, 2025 |
| Whittemore Tingley | Chief Medical Officer · Since at least Jul 29, 2021 |
| Whit Tingley | Chief Medical Officer · Since at least Jun 3, 2026 |